ALT - Altimmune, Inc.
2.6
-0.030 -1.154%
Share volume: 5,638,491
Last Updated: 04-30-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$2.63
-0.03
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-13-2025 | 08-12-2025 | 11-06-2025 | 03-06-2026 | |
| Cash flow financing | -261.000 K | -46.000 K | 266.000 K | 10.085 M | 34.119 M | 52.244 M | 39.349 M | 81.130 M | |
| Other financing cash flows | -430.000 K | -46.000 K | 135.000 K | 91.000 K | -799.000 K | -175.000 K | 33.000 K | -165.000 K | |
| Cash flow | -56.139 M | -21.850 M | -25.653 M | 5.452 M | 12.178 M | 134.001 M | -121.869 M | -17.476 M | |
| Net income | -24.394 M | -24.640 M | -22.845 M | -23.180 M | -19.575 M | -22.146 M | -19.014 M | -27.358 M | |
| Depreciation | 107.000 K | 61.000 K | 37.000 K | 33.000 K | 29.000 K | 30.000 K | 27.000 K | 26.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -39.521 M | -3.696 M | 1.199 M | 13.632 M | -5.101 M | 101.107 M | -149.321 M | -79.158 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.000 K | |
| Cash Change | -56.139 M | -21.850 M | -25.653 M | 5.452 M | 12.178 M | 134.001 M | -121.869 M | -17.476 M |